Does Delta Hemoglobin-Albumin-Lymphocyte Platelet (HALP) Score Predict the Risk of Early Progression in Patients Treated with CDK4/6 Inhibitors?
Aim: This study aims to determine the predictive value of dynamic change in hemoglobin-albumin-lymphocyte-platelet (HALP) score on treatment response in hormone-positive metastatic breast cancer patients receiving cyclin-dependent kinase (CDK) 4/6 inhibitors. Materials and Methods: This study was d...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Galenos Yayincilik
2024-12-01
|
| Series: | Namık Kemal Tıp Dergisi |
| Subjects: | |
| Online Access: | https://namikkemalmedj.com/articles/does-delta-hemoglobin-albumin-lymphocyte-platelet-halp-score-predict-the-risk-of-early-progression-in-patients-treated-with-cdk46-inhibitors/doi/nkmj.galenos.2024.12599 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|